Ethypharm, the speciality pharmaceutical company focused on CNS and critical care medicines, has confirmed its offer to supply 10,000 Naloxone kits across 2021 to The Drug Deaths Taskforce. The company, which is the licence holder for Prenoxad Injection, has made the gesture to support the work of the Taskforce in increasing engagement, overdose prevention education and naloxone training and supply with people at risk of overdose and their families. Prenoxad is the world’s first ‘take-home’ naloxone presentation licensed for use in a non-medical setting.